Skip to main content
. 2021 Aug;149:106625. doi: 10.1016/j.ypmed.2021.106625

Table 3.

Participation in screening.

Screening participation age 50–64y Aged 65-69y
Aged 70-74y
Aged 75-79y
Aged 80-84y
Aged 65-84y
Cases (N) PYa 1000's Risk per 1000 PYa (95% CI) Cases (N) PYa 1000's Risk per 1000 PYa (95% CI) Cases (N) PYa 1000's Risk per 1000 PYa (95% CI) Cases (N) PYa 1000's Risk per 1000 PYa (95% CI) 20-year cumulative absolute risk per 1000 PYa 20-year differenceb in absolute risk per 1000 PYa (95% CI)
No screening 485 1237 0.39 (0.34, 0.46) 295 1007 0.29 (0.25, 0.35) 295 975 0.30 (0.26, 0.36) 134 548 0.24 (0.19–0.31) 6.16 (5.64, 6.72)
Screened irregularly 249 2255 0.11 (0.10, 0.13) 223 1632 0.14 (0.12, 0.16) 294 2195 0.13 (0.12, 0.15) 202 1559 0.13 (0.11–0.15) 2.55 (2.35, 2.76) 3.61 (3.08, 4.23)
Screened regularly 266 5557 0.05 (0.04, 0.06) 286 4032 0.07 (0.06, 0.08) 228 2403 0.10 (0.08, 0.11) 60 564 0.11 (0.08–0.14) 1.60 (1.43, 1.79) 4.56 (4.02, 5.16)

Annual and 20-year cumulative risk of cervical cancer per 1000 women (with a cervix) by age at diagnosis and screening participation age 50–64y. Constrains were not necessary.

a

Person years.

b

Relative to “no screening”: Amount by which risk is lower.